198 related articles for article (PubMed ID: 15211974)
1. [Breast cancer and the use of hormones around menopause].
Boukes FS; Groeneveld FP; Goudswaard AN
Ned Tijdschr Geneeskd; 2004 Jun; 148(23):1170. PubMed ID: 15211974
[No Abstract] [Full Text] [Related]
2. [Breast cancer and the use of hormones around menopause].
de Vries I; Wallis F
Ned Tijdschr Geneeskd; 2004 Mar; 148(13):638. PubMed ID: 15083631
[No Abstract] [Full Text] [Related]
3. Exogenous sex hormones and risk of breast cancer.
Smetnik V; Konovalova V
Gynecol Endocrinol; 2010 Mar; 26(3):149-51. PubMed ID: 19626508
[No Abstract] [Full Text] [Related]
4. [Use of hormone-replacement therapy and steroid contraceptives in menopause as an oncological and epidemiological problem: is it a risk and/or benefit?].
Bershteĭn LM
Vopr Onkol; 2005; 51(6):636-46. PubMed ID: 17037027
[No Abstract] [Full Text] [Related]
5. Age and menopausal effects of hormonal birth control and hormone replacement therapy in relation to breast cancer risk.
Shantakumar S; Terry MB; Paykin A; Teitelbaum SL; Britton JA; Moorman PG; Kritchevsky SB; Neugut AI; Gammon MD
Am J Epidemiol; 2007 May; 165(10):1187-98. PubMed ID: 17337757
[TBL] [Abstract][Full Text] [Related]
6. Oral oestrogen-progestagen contraceptives, menopausal treatment, and cancer.
Shapiro S
Lancet Oncol; 2005 Oct; 6(10):736; author reply 737. PubMed ID: 16198976
[No Abstract] [Full Text] [Related]
7. [Hormonal contraceptives and their relationship to breast cancer].
Habánová M; Svikruhová J; Sláviková E
Klin Onkol; 2010; 23(6):428-32. PubMed ID: 21351420
[TBL] [Abstract][Full Text] [Related]
8. [Hormone replacement therapy in peri- and postmenopausal women and breast cancer risk].
Buchholz S; Horn F; Ortmann O
Ther Umsch; 2008 Apr; 65(4):231-4. PubMed ID: 18622916
[TBL] [Abstract][Full Text] [Related]
9. [Breast cancer and the use of the hormones around the menopause].
van der Mooren MJ; Kenemans P
Ned Tijdschr Geneeskd; 2004 May; 148(20):1009-10; author reply 1010-1. PubMed ID: 15181729
[No Abstract] [Full Text] [Related]
10. [Breast cancer and the use of the hormones around the menopause].
Mourits MJ; van der Zee AG
Ned Tijdschr Geneeskd; 2004 Jan; 148(2):108; author reply 108-9. PubMed ID: 14753135
[No Abstract] [Full Text] [Related]
11. [Migraine from a female perspective].
Dahlöf C; Ehrenborg A
Lakartidningen; 2007 Jun 4-11; 104(23):1812-4. PubMed ID: 17655028
[No Abstract] [Full Text] [Related]
12. Oral contraceptives and the risk of breast cancer.
Grant EC
N Engl J Med; 2002 Oct; 347(18):1448-9; author reply 1448-9. PubMed ID: 12418035
[No Abstract] [Full Text] [Related]
13. [Breast cancer and hormone replacement therapy around menopause].
Franke HR; Schram JH; van der Mooren MJ
Ned Tijdschr Geneeskd; 2003 Sep; 147(39):1934-5; author reply 1935. PubMed ID: 14560695
[No Abstract] [Full Text] [Related]
14. [Natural remedies and hormone preparations--potential risk for breast cancer patients. A study surveys the use of agents which possibly counteract with the treatment].
Malekzadeh F; Rose C; Ingvar C; Jernström H
Lakartidningen; 2005 Oct 31-Nov 6; 102(44):3226-8, 3230-1. PubMed ID: 16329453
[TBL] [Abstract][Full Text] [Related]
15. Behavior of estrogen-associated female genital tract cancer and its relation to neoplasia following intrauterine exposure to diethylstilbestrol (DES).
Herbst AL
Gynecol Oncol; 2000 Feb; 76(2):147-56. PubMed ID: 10637063
[No Abstract] [Full Text] [Related]
16. Effect of reproductive factors and oral contraceptives on breast cancer risk in BRCA1/2 mutation carriers and noncarriers: results from a population-based study.
Lee E; Ma H; McKean-Cowdin R; Van Den Berg D; Bernstein L; Henderson BE; Ursin G
Cancer Epidemiol Biomarkers Prev; 2008 Nov; 17(11):3170-8. PubMed ID: 18990759
[TBL] [Abstract][Full Text] [Related]
17. An overview of studies on estrogens, oral contraceptives and breast cancer.
Drill VA
Prog Drug Res; 1981; 25():159-87. PubMed ID: 6796999
[No Abstract] [Full Text] [Related]
18. The impact of hormone replacement therapy on the incidence of breast cancer in Norway.
Bakken K; Lund E; Eggen AE
J Clin Oncol; 2005 May; 23(15):3636-7; author reply 3637-8. PubMed ID: 15908680
[No Abstract] [Full Text] [Related]
19. [Increased risk of breast cancer following hormone replacement therapy during climacteric. 3 440 extra cases might have been caused by the treatment in Sweden during the 1990s].
Magnusson C; Reeves G
Lakartidningen; 2005 Apr 18-24; 102(16):1228-30. PubMed ID: 15921095
[No Abstract] [Full Text] [Related]
20. [Hormonal replacement therapy in postmenopause: an endless story].
Parazzini F
Epidemiol Prev; 2002; 26(6):278-9. PubMed ID: 12619490
[No Abstract] [Full Text] [Related]
[Next] [New Search]
